Search Ontology:
ChEBI

EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitor

Term ID
CHEBI:138953
Synonyms
  • deamido-NAD(+):L-glutamine amido-ligase (AMP-forming) inhibitor
  • deamido-NAD(+):L-glutamine amido-ligase (AMP-forming) inhibitors
  • desamidonicotinamide adenine dinucleotide amidotransferase inhibitor
  • desamidonicotinamide adenine dinucleotide amidotransferase inhibitors
  • DPN synthetase inhibitor
  • DPN synthetase inhibitors
  • EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitors
  • EC 6.3.5.1 inhibitor
  • EC 6.3.5.1 inhibitors
  • NAD synthetase (glutamine-hydrolysing) inhibitor
  • NAD synthetase (glutamine-hydrolysing) inhibitors
  • NAD(+) synthase (glutamine-hydrolysing) (EC 6.3.5.1) inhibitor
  • NAD(+) synthase (glutamine-hydrolysing) (EC 6.3.5.1) inhibitors
  • NAD(+) synthase (glutamine-hydrolysing) inhibitor
  • NAD(+) synthase (glutamine-hydrolysing) inhibitors
  • NAD(+) synthetase (glutamine-hydrolyzing) inhibitor
  • NAD(+) synthetase (glutamine-hydrolyzing) inhibitors
  • nicotinamide adenine dinucleotide synthetase (glutamine) inhibitor
  • nicotinamide adenine dinucleotide synthetase (glutamine) inhibitors
Definition
Any EC 6.3.5.* (carbon-nitrogen ligases with glutamine as amido-N-donor) inhibitor that interferes with the action of NAD(+) synthase (glutamine-hydrolysing) (EC 6.3.5.1).
References
Ontology
ChEBI  ( EBI )
Relationships
is a type of
inverse has_role
Phenotype
Phenotype resulting from EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitor
Phenotype where environments contain EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitor
Phenotype modified by environments containing EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitor
Human Disease Model